Search in:

Journal of Blood Medicine Volume 14, 2023 - Issue

Submit an article Journal homepage

Open access

413

Views

CrossRef citations to date

Altmetric

ORIGINAL RESEARCH

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines

Hana Qasim1 Hematology-Oncology Department, National Centre for Cancer Care & Research, Doha, Qatar;2 Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USACorrespondence[email protected] [email protected]

https://orcid.org/0000-0002-9354-6314

Alaa Rahhal3 MSc Pharmacy Department, Hamad Medical Corporation, Doha, Qatar

Ahmed Husain4 Infectious Disease Department, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar

Abdelkarim Alammora5 Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar

Khaled Alsa’ed5 Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar

Ahmed Abdelghafar Masaad Alsayed5 Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar

https://orcid.org/0000-0002-2820-975X

Baha Faiyoumi5 Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar

Leen Maen AbuAfifeh5 Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar

Mohammad Abu-Tineh1 Hematology-Oncology Department, National Centre for Cancer Care & Research, Doha, Qatar

https://orcid.org/0000-0002-2984-0252

Awni Alshurafa1 Hematology-Oncology Department, National Centre for Cancer Care & Research, Doha, Qatar

Mohamed A Yassin1 Hematology-Oncology Department, National Centre for Cancer Care & Research, Doha, Qatar

https://orcid.org/0000-0002-1144-8076

show all

Pages 295-302 | Received 10 Nov 2022, Accepted 06 Mar 2023, Published online: 14 Apr 2023

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Vaillant AAJ, Gupta N. ITP-immune thrombocytopenic purpura. StatPearls; 2022; Available from: https://www.ncbi.nlm.nih.gov/books/NBK537240/. Accessed March 31, 2023.
Google Scholar
Immune thrombocytopenia (ITP): practice essentials, background, pathophysiology; 2021. Available from: https://emedicine.medscape.com/article/202158-overview. Accessed March 31, 2023.
Google Scholar
Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386–401. doi:10.1111/imm.13443
PubMed Web of Science ®Google Scholar
Jawed M, Khalid A, Rubin M, Shafiq R, Cemalovic N. Acute immune thrombocytopenia (ITP) following COVID-19 vaccination in a patient with previously stable ITP. Open Forum Infect Dis. 2021;8(7). doi:10.1093/ofid/ofab343
PubMed Web of Science ®Google Scholar
Qasim H, Ali E, Yassin MA. Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases. 2021;26:e01344. doi:10.1016/j.idcr.2021.e01344
PubMed Web of Science ®Google Scholar
Kuter DJ. Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J Haematol. 2021;195(3):365–370. doi:10.1111/bjh.17645
PubMed Web of Science ®Google Scholar
van Dijk Roger M, Schutgens WE, Roger Schutgens CE, Schutgens RE. Relapse of immune thrombocytopenia after COVID-19 vaccination. Eur J Haematol. 2022;108(1):84–85. doi:10.1111/ejh.13713
PubMed Web of Science ®Google Scholar
Corbett KS, Flynn B, Foulds KE, et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N Engl J Med. 2020;383(16):1544–1555. doi:10.1056/NEJMoa2024671
PubMed Web of Science ®Google Scholar
Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589–593. doi:10.1038/s41586-020-2639-4
PubMed Web of Science ®Google Scholar
Chagla Z. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose. Ann Intern Med. 2021;174(3):JC28–9. doi:10.7326/ACPJ202103160-028
PubMed Web of Science ®Google Scholar
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
PubMed Web of Science ®Google Scholar
Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol. 2022;41(5):1603. doi:10.1007/s10067-022-06149-4
PubMed Web of Science ®Google Scholar
Fragkou PC, Dimopoulou D. Serious complications of COVID-19 vaccines: a mini-review. Metabol Open. 2021;12:100145. doi:10.1016/j.metop.2021.100145
PubMedGoogle Scholar
Lee EJ, Beltrami-Moreira M, Al-Samkari H, et al. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Blood. 2022;139(10):1564. doi:10.1182/blood.2021013411
PubMed Web of Science ®Google Scholar
Perricone C, Ceccarelli F, Nesher G, et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014;60(2–3):226–235. doi:10.1007/s12026-014-8597-x
PubMed Web of Science ®Google Scholar
France EK, Glanz J, Xu S, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121(3):e687–e692. doi:10.1542/peds.2007-1578
PubMed Web of Science ®Google Scholar
Schmidt N, Maitland H. Acute immune thrombocytopenia following administration of Shingrix recombinant zoster vaccine. Am J Hematol. 2021;96(5):E136–7. doi:10.1002/ajh.26143
PubMed Web of Science ®Google Scholar
Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96(5):534–537. doi:10.1002/ajh.26132
PubMed Web of Science ®Google Scholar
Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med. 2009;275(7):352–356. doi:10.1056/NEJM196608182750703
Google Scholar
Helms JM, Ansteatt KT, Roberts JC, et al. Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. J Blood Med. 2021;12:221. doi:10.2147/JBM.S307047
PubMed Web of Science ®Google Scholar
Visser C, Swinkels M, van Werkhoven ED, et al. COVID-19 vaccination in patients with immune thrombocytopenia. Blood Adv. 2022;6(6):1637–1644. doi:10.1182/bloodadvances.2021006379
PubMed Web of Science ®Google Scholar
McCrae K. Immune thrombocytopenia: no longer ‘idiopathic’. Cleve Clin J Med. 2011;78(6):358. doi:10.3949/ccjm.78gr.10005
PubMedGoogle Scholar
Real world. Available from: https://www.sciencedirect.com/science/article/pii/S0006497118600497. Accessed March 31, 2023.
Google Scholar
Ali E, Al-maharmeh Q, Rozi WM, Habib MB, Yassin M. Immune thrombocytopenia purpura flare post COVID-19 vaccine. Ann Med Surg. 2022;75:103164. doi:10.1016/j.amsu.2021.103164
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date